Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast calculations
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of cervical cancer globally
3.2.1.2 Several initiatives undertaken by government and other organizations to spread disease awareness
3.2.1.3 Rising incidence of HPV Infections
3.2.1.4 Advancements in diagnostic technologies
3.2.2 Industry pitfalls & challenges
3.2.2.1 Limited access to healthcare services
3.2.2.2 Social stigma and cultural barriers
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Porter’s analysis
3.6.1 Supplier power
3.6.2 Buyer power
3.6.3 Threat of new entrants
3.6.4 Threat of substitutes
3.6.5 Industry rivalry
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive analysis of major market players
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Diagnostic Methods, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Pap smear tests
5.3 HPV DNA tests
5.4 Colposcopy
5.5 Biopsy and endocervical curettage
5.6 Other diagnostic methods
Chapter 6 Market Estimates and Forecast, By Age Group, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 20-40 years
6.3 Above 40 years
Chapter 7 Market Estimates and Forecast, By End-Use, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 Diagnostic laboratories
7.4 Diagnostic imaging centers
7.5 Cancer research institutes
7.6 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 Arbor Vita Corporation
9.3 Becton, Dickinson and Company (BD)
9.4 Danaher Corporation
9.5 F. Hoffmann-La Roche Ltd
9.6 Fujirebio Diagnostics, Inc.
9.7 Hologic, Inc.
9.8 QIAGEN
9.9 Seegene Inc
9.10 Thermo Fisher Scientific Inc.
